CN104519961A - 用于神经退行性疾病或中枢神经系统的其他疾病的鼻内治疗的含有生长因子的组合物,及其制造方法 - Google Patents

用于神经退行性疾病或中枢神经系统的其他疾病的鼻内治疗的含有生长因子的组合物,及其制造方法 Download PDF

Info

Publication number
CN104519961A
CN104519961A CN201380041280.4A CN201380041280A CN104519961A CN 104519961 A CN104519961 A CN 104519961A CN 201380041280 A CN201380041280 A CN 201380041280A CN 104519961 A CN104519961 A CN 104519961A
Authority
CN
China
Prior art keywords
composition
nervous system
central nervous
diseases
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380041280.4A
Other languages
English (en)
Chinese (zh)
Inventor
E·阿尼图亚阿尔德科亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTI Biotechnology Insttitute
Original Assignee
BTI Biotechnology Insttitute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49111229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104519961(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BTI Biotechnology Insttitute filed Critical BTI Biotechnology Insttitute
Publication of CN104519961A publication Critical patent/CN104519961A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN201380041280.4A 2012-08-09 2013-07-19 用于神经退行性疾病或中枢神经系统的其他疾病的鼻内治疗的含有生长因子的组合物,及其制造方法 Pending CN104519961A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201200810 2012-08-09
ES201200810A ES2442242B1 (es) 2012-08-09 2012-08-09 Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
PCT/ES2013/000176 WO2014023860A1 (es) 2012-08-09 2013-07-19 Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas

Publications (1)

Publication Number Publication Date
CN104519961A true CN104519961A (zh) 2015-04-15

Family

ID=49111229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380041280.4A Pending CN104519961A (zh) 2012-08-09 2013-07-19 用于神经退行性疾病或中枢神经系统的其他疾病的鼻内治疗的含有生长因子的组合物,及其制造方法

Country Status (17)

Country Link
US (2) US20140044795A1 (https=)
EP (1) EP2883569B1 (https=)
JP (1) JP6339568B2 (https=)
KR (1) KR102149162B1 (https=)
CN (1) CN104519961A (https=)
AR (1) AR092086A1 (https=)
BR (1) BR112015002760A2 (https=)
CA (1) CA2881075A1 (https=)
CL (1) CL2014003510A1 (https=)
CO (1) CO7170177A2 (https=)
ES (2) ES2442242B1 (https=)
IN (1) IN2014MN02675A (https=)
MX (1) MX357828B (https=)
PE (1) PE20150616A1 (https=)
RU (1) RU2696497C2 (https=)
TW (1) TWI649084B (https=)
WO (1) WO2014023860A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2016003282A1 (es) 2016-12-21 2017-08-18 Univ Chile Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033813A1 (en) * 1998-12-09 2000-06-15 Chiron Corporation Administration of neurotrophic agents to the central nervous system
EP1066838A1 (en) * 1999-01-26 2001-01-10 Eduardo Anitua Aldecoa Bone tissue regenerating composition
CN102573943A (zh) * 2009-10-23 2012-07-11 世元世龙技术株式会社 通过活化富血小板血浆（prp)诱导组织再生的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
ES2221770B2 (es) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
JP5276982B2 (ja) * 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
EP2152240A4 (en) * 2007-06-08 2012-05-09 Healthpartners Res Foundation PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
ES2333498B1 (es) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
MX2010002716A (es) * 2007-09-14 2010-07-05 Scil Technology Gmbh Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
CA2761603C (en) 2009-05-14 2018-06-05 Biotechnology Institute, I Mas D, S.L. Method for the preparation of at least one compound from blood, and extraction device for use in the execution of said method
ES2369945B1 (es) 2011-07-29 2012-10-15 Eduardo Anitua Aldecoa Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033813A1 (en) * 1998-12-09 2000-06-15 Chiron Corporation Administration of neurotrophic agents to the central nervous system
EP1066838A1 (en) * 1999-01-26 2001-01-10 Eduardo Anitua Aldecoa Bone tissue regenerating composition
CN102573943A (zh) * 2009-10-23 2012-07-11 世元世龙技术株式会社 通过活化富血小板血浆（prp)诱导组织再生的组合物及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李晓红等: "移植活化富血小板血浆上清液促进实验性大鼠心肌梗死后组织修复", 《中国动脉硬化杂志》 *

Also Published As

Publication number Publication date
MX2015001677A (es) 2015-04-10
CL2014003510A1 (es) 2015-05-04
JP2015524464A (ja) 2015-08-24
US20160184360A1 (en) 2016-06-30
WO2014023860A1 (es) 2014-02-13
CO7170177A2 (es) 2015-01-28
KR20150040860A (ko) 2015-04-15
KR102149162B1 (ko) 2020-08-31
PE20150616A1 (es) 2015-05-25
EP2883569A1 (en) 2015-06-17
EP2883569B1 (en) 2017-12-20
ES2662385T3 (es) 2018-04-06
ES2442242A1 (es) 2014-02-10
RU2696497C2 (ru) 2019-08-02
AR092086A1 (es) 2015-03-25
IN2014MN02675A (https=) 2015-08-28
BR112015002760A2 (pt) 2020-04-22
RU2015104076A (ru) 2016-09-27
TW201408310A (zh) 2014-03-01
TWI649084B (zh) 2019-02-01
ES2442242B1 (es) 2014-11-25
US20140044795A1 (en) 2014-02-13
MX357828B (es) 2018-07-25
JP6339568B2 (ja) 2018-06-06
CA2881075A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
JP6401757B2 (ja) 臍帯血細胞を用いた脳損傷の処置
Yao et al. Tetrahedral framework nucleic acids facilitate neurorestoration of facial nerves by activating the NGF/PI3K/AKT pathway
Fadeev et al. Combination of epidural electrical stimulation with ex vivo triple gene therapy for spinal cord injury: a proof of principle study
M. Corbett et al. Increasing neurogenesis with fluoxetine, simvastatin and ascorbic acid leads to functional recovery in ischemic stroke
Zhou et al. Transcranial direct current stimulation alleviated ischemic stroke induced injury involving the BDNF-TrkB signaling axis in rats
KR102405411B1 (ko) Ｐｔｅｎ 저해제를 사용한 손상된 신경의 치료
Zheng et al. Nerve root magnetic stimulation improves locomotor function following spinal cord injury with electrophysiological improvements and cortical synaptic reconstruction
Yao et al. Transcranial pulsed current stimulation alleviates neuronal pyroptosis and neurological dysfunction following traumatic brain injury via the orexin-A/NLRP3 pathway
IT201900002109A1 (it) Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
CN104519961A (zh) 用于神经退行性疾病或中枢神经系统的其他疾病的鼻内治疗的含有生长因子的组合物,及其制造方法
Cioato et al. Transcranial direct current stimulation did not revert the increased central and peripheral NGF levels induced by neuropathic pain in rats
KR20230117190A (ko) Pten 억제제에 의한 척수 손상의 치료
Hwang et al. Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway
JP2001511136A (ja) Ｃｍ１０１／ｇｂｓ毒素による神経損傷の修復の促進
Hesse 11 Surgical Treatments
Chen et al. Electroacupuncture Modulation of Chondroitin Sulfate Glycosaminoglycan Promotes the Repair of Damaged Spinal Cord in Rats
De Berdt Spinal cord injury: how could dental stem cells from human apical papilla take up the challenge?
JP2024539499A5 (https=)
CN118215669A (zh) 异野漆树苷及其衍生物用于促进神经修复的用途
Combs et al. Lolitrem B Intoxication Activates Neuronal Stress Pathways

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150415